Differences in the Radius of Curvature Between Femoral Condyles: Implications for Osteochondral Allograft Matching.

J Bone Joint Surg Am

Departments of Orthopaedic Surgery (K.L.M., D.R.M., and K.J.J.) and Radiology (B.D.L.), David Geffen School of Medicine at UCLA, Los Angeles, California.

Published: August 2018

Background: The radius of curvature (ROC) is an important variable related to potential cartilage incongruities in the transplantation of a large femoral osteochondral allograft. The anterior-posterior length (APL) of a condyle is used as a criterion for donor-graft acceptance. We hypothesized that there would be a linear correlation between the ROC and APL of a condyle, that the ROC and APL would differ significantly between the medial femoral condyle (MFC) and the lateral femoral condyle (LFC), and that a donor graft from the LFC would be suitable for an MFC defect.

Methods: Knee magnetic resonance imaging scans of 147 patients with no cartilage defects were analyzed. Best-fit circles in the sagittal plane were determined at standardized locations on each condyle. Assuming the use of a 20-mm graft that was flush to the edges of the native cartilage, the central graft prominence was calculated for potential donor-host differences in the ROC.

Results: There was a linear correlation between the ROC and APL. There were significant differences in the mean ROC and APL between the MFC and LFC. Based on calculations of the central graft prominence among all ROC combinations within the patient group, 100% of potential medial-to-medial, 97.8% of lateral-to-lateral, and 92.5% of lateral-to-medial transplantations would produce a central graft prominence of <1 mm. On average, an allograft harvested from an LFC (mean ROC, 25.7 mm; mean APL, 69.8 mm) implanted into an MFC defect site (mean ROC, 31.9 mm; mean APL, 66.6 mm) would have a central graft prominence of 0.4 ± 0.3 mm.

Conclusions: Assuming a maximum central graft prominence tolerance of +1 mm, our findings demonstrate that matching the ROC or APL would not be necessary for potential medial-to-medial or lateral-to-lateral allograft transplants within this patient group. Implantation of an LFC donor allograft into an MFC defect is also supported by our findings.

Download full-text PDF

Source
http://dx.doi.org/10.2106/JBJS.17.01509DOI Listing

Publication Analysis

Top Keywords

roc apl
16
central graft
12
graft prominence
12
radius curvature
8
osteochondral allograft
8
apl condyle
8
linear correlation
8
correlation roc
8
femoral condyle
8
roc
6

Similar Publications

Background: Acute promyelocytic leukemia (APL) is frequently associated with disseminated intravascular coagulation (DIC), leading to potentially life-threatening bleeding. Compared to bleeding, thromboses are a less commonly encountered problem.

Objective: The objective of our study was to identify the incidence and predictive value of demographic data, clinical-laboratory parameters, and thrombosis risk assessment models (RAMs) for venous thromboembolism (VTE) in patients with APL.

View Article and Find Full Text PDF

Background: The 2023 American College of Rheumatology and modified Sapporo criteria for antiphospholipid syndrome (APS) recommend ELISA to detect anticardiolipin (aCL) and anti-β2-glycoprotein I (aβ2GP1) IgG/IgM antibodies, focusing on moderate to high levels or exceeding the 99th percentile. This study aims to establish the 99th percentile threshold for anti-phospholipid (aPL) antibodies and compare the diagnostic accuracies of these thresholds with manufacturer cutoffs using 2 methodologies.

Methods: The 99th percentile cutoffs for aPL antibodies from 305 healthy donors were established using Aptiva, Particle-Based Multi-Analyte Technology (PMAT), and QUANTA Lite (QL) ELISA, following nonparametric reference interval estimation.

View Article and Find Full Text PDF

Association Between Novel Antiphospholipid Antibodies and Adverse Pregnancy Outcomes.

Obstet Gynecol

January 2025

University of Utah and ARUP Laboratories, Salt Lake City, and Intermountain Health, Murray, Utah; the Hospital for Special Surgery, New York, New York; and Oregon Health & Science University, Portland, Oregon.

Objective: To investigate the value of anti-β2 glycoprotein-I domain 1 (aD1) and antiphosphatidylserine-prothrombin antibodies for predicting adverse pregnancy outcomes in an at-risk population and to describe the relationship among aD1, antiphosphatidylserine-prothrombin, lupus anticoagulant, and other antiphospholipid antibodies (aPL).

Methods: Data were obtained from a prospective cohort of pregnant patients with aPL, with systemic lupus erythematosus (SLE) (n=59) or without SLE (n=106), or SLE without aPL (n=100) (PROMISSE [Predictors of Pregnancy Outcome in Systemic Lupus Erythematosus and Antiphospholipid Syndrome] study; NCT00198068). Levels of aD1 and antiphosphatidylserine-prothrombin were quantified with the QUANTA Flash and QUANTA Lite systems, respectively, in sera collected at less than 18 weeks of gestation.

View Article and Find Full Text PDF

This study explores the mechanisms of glucocorticoid-induced osteoporosis (OP) and Rheumatoid arthritis (RA), focusing on apoptosis and its role in the progression from RA to OP. Using microarray data from the GEO database, differential gene expression analysis was conducted with the limma package, identifying significant genes in RA and OP. Weighted Gene Co-expression Network Analysis (WGCNA) further examined gene relationships with the disease status, identifying co-expression patterns.

View Article and Find Full Text PDF

Objective: To analyze the correlation between serum fibronectin 3 (Ficolin-3) levels and early severe bleeding in newly diagnosed acute promyelocytic leukemia (APL) patients.

Methods: A total of 125 patients with newly diagnosed APL admitted to Shanxi Bethune Hospital from January 2020 to August 2023 were selected. All patients were given all-trans retinoic acid+arsenic for induction therapy.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!